Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;35(10):1987-1993.
doi: 10.1111/jdv.17335. Epub 2021 May 27.

Measurement properties of patient-reported outcome measures for eczema control: a systematic review

B L Stuart  1 , L Howells  2 , R L Pattinson  3 , J R Chalmers  2 , D Grindlay  2 , N K Rogers  2 , E Grinich  4 , T Pawlitschek  4 , E L Simpson  4 , K S Thomas  2
Affiliations

Measurement properties of patient-reported outcome measures for eczema control: a systematic review

B L Stuart et al. J Eur Acad Dermatol Venereol. 2021 Oct.

Abstract

Atopic eczema (herein referred to as 'eczema') is a skin disease characterized by remitting and relapsing symptoms. The Harmonising Outcome Measures for Eczema (HOME) initiative was developed to establish a core outcome set (COS) for eczema to be measured for all future eczema trials. The core outcome set for atopic eczema clinical trials includes the domain for patient-reported eczema control, but a review of the validation of available eczema control instruments was lacking. We aimed to review the literature and systematically assess the measurement properties of validated patient-reported outcome instruments that capture eczema control. PubMed and Ovid EMBASE were searched up to 24 January 2020 for any study that reported on PROM instrument development or validation. The COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) criteria were used to assess the quality of eligible studies. We screened 12 036 titles and abstracts and 58 full texts. A total of 12 papers were included, reporting on seven PROMS. These were assessed with respect to development, reliability, construct validity and responsiveness. Two instruments, Recap of Atopic Eczema (RECAP) and the Atopic Dermatitis Control Tool (ADCT), have been developed and validated to a sufficient standard to support their recommendation as patient-reported outcome instruments for measuring control of atopic eczema as part of the HOME Core Outcome Set.

PubMed Disclaimer

References

    1. Schofield JK, Grindlay DJC, Williams HC. Skin conditions in the UK: a health care needs assessment. Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK, 2009.
    1. Schmitt J, Spuls P, Boers M et al. Towards global consensus on outcome measures for atopic eczema research: Results of the HOME II meeting. Allergy: Eur J Allergy Clin Immunol 2012; 67: 1111-1117.
    1. Howells L, Thomas KS, Sears AV et al. Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema. J Eur Acad Dermatol Venereol 2019; 33: 1124-1132.
    1. Chalmers JR, Thomas KS, Apfelbacher C et al. Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol Blackwell Publishing Ltd 2018; 178: e332-e341.
    1. Barbarot S, Rogers NK, Abuabara K et al. Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review. J Am Acad Dermatol 2016; 75: 1038-1044.

Publication types

LinkOut - more resources